
Associate Professor of Urology
Department of Surgical, Oncological and Gastroenterological Sciences (DiSCOG)
University of Padova
I am Associate Professor of Urology at the University of Padova (www.unipd.it). The University of Padova is one of the oldest academic institutions in the world, with over 800 years of history.
My clinical activity is based at the Urology Unit of the Padova University Hospital (www.aopd.veneto.it). Over the past four years, this department has been consistently ranked by Newsweek magazine as one of the best urology units in Europe and the best urology department in Italy (rankings.newsweek.com).
Clinically, I specialise in the diagnosis, treatment, and follow-up of the main uro-oncological conditions, with a particular focus on prostate, bladder, kidney, upper urinary tract, testicular, and penile cancers. These procedures are now performed almost exclusively using robotic approaches, although I have extensive experience in laparoscopic surgery for renal and penile pathology, and open surgery for advanced bladder and renal cancers.
I also manage endoscopic and surgical treatments for patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia or overactive bladder syndrome. In the reconstructive field, I perform robotic repair of female genitourinary prolapse, ureteropelvic junction obstruction, and ureteral strictures.
I have been teaching urology for over 10 years to undergraduate medical and nursing students at the University of Padova (including the Treviso campus) and to urology and surgical residents in various speciality training programmes.
In terms of research, I have published several hundred peer-reviewed articles in indexed international journals. My main areas of interest include urological oncology and functional urology, with a particular focus on prognostic factors in prostate, kidney, bladder, and upper tract urothelial carcinoma, outcomes of robotic surgery in oncological and functional urology, and robotic surgical training.
|
5,000+
Surgical procedures
|
600+
Scientific publications
↻ updated via OpenAlex
|
|
20+
Years of clinical activity
|
103
H-index
↻ updated via OpenAlex
|
|
10+
Years of academic teaching
|
36,000+
Total citations
↻ updated via OpenAlex
|
Teaching of urology to undergraduate medical and nursing students at the University of Padova (Padova and Treviso campuses) and to residents enrolled in multiple postgraduate speciality training programmes at the University of Padova.
Key international institutions I have collaborated with:
Robotic surgery represents one of the most significant advances in modern medicine. In urology, this technology has transformed the management of many conditions, offering patients more precise, less invasive procedures with significantly shorter recovery times.
The most widely used robotic platform worldwide is the Da Vinci system, which allows the surgeon to operate through small incisions — just a few millimetres — with high-definition three-dimensional vision and wristed instruments capable of movements beyond the range of the human hand. The surgeon guides the robot in real time from a dedicated console, maintaining complete control of the procedure at every moment.
The system consists of three main components:
The surgeon never loses control of the procedure: every movement of the robotic arms is a direct, precise translation of the surgeon's hand movements. The system automatically filters involuntary tremors and amplifies surgical dexterity.
Robot-assisted radical prostatectomy allows removal of the prostate with maximum precision, preserving the neurovascular bundles responsible for erectile function and the continence mechanism, with reduced blood loss and faster recovery compared to open surgery.
Robot-assisted partial nephrectomy allows resection of only the tumour-bearing portion of the kidney, preserving healthy parenchyma, with shorter warm ischaemia times and better long-term renal function compared to conventional laparoscopy.
Robot-assisted radical cystectomy allows removal of the bladder with reduced blood loss, fewer transfusion requirements, and shorter hospital stay. In high-volume centres, intracorporeal neobladder reconstruction is also feasible.
The robotic approach is also used for ureteropelvic junction obstruction (pyeloplasty), female genitourinary prolapse repair, and complex ureteral strictures, with excellent outcomes and rapid recovery.
Compared to conventional open surgery, robotic surgery offers numerous advantages documented in the international scientific literature:
Reduced blood lossLower risk of intraoperative transfusion.
Minimal incisionsLess postoperative pain and improved cosmesis.
Shorter hospital stayFaster return to normal daily activities.
Lower infection riskReduced wound complications.
Greater precisionBetter preservation of neurovascular structures.
Better functional outcomesFaster recovery of urinary continence and erectile function after prostatectomy.
Equivalent or superior oncological outcomesReduced positive surgical margins compared to open surgery.
Before surgery, each patient undergoes a thorough assessment to establish whether robotic surgery is the most appropriate approach for their specific clinical situation. Not all conditions and not all patients are ideal candidates: the treatment decision is always discussed with the patient, taking into account the disease characteristics, general health status, and individual expectations.
After surgery, most patients are able to mobilise and eat within the first few hours, with a median hospital stay ranging from 1 to 4 days depending on the procedure. Postoperative follow-up is planned with regular appointments to monitor both oncological outcomes and functional recovery.
Patient information on the main urological cancers
PSA, biopsy, robot-assisted radical prostatectomy, radiotherapy, hormonal therapy
Available Bladder CancerUrothelial carcinoma, NMIBC, MIBC, TURBT, BCG, radical cystectomy, systemic therapies
Available Upper Tract Urothelial CarcinomaUTUC, radical nephroureterectomy, conservative management, POUT, EV-pembrolizumab
Available Kidney CancerRenal cell carcinoma, Bosniak classification, partial nephrectomy, metastatic treatment
Available Testicular CancerSeminoma, non-seminoma, radical orchiectomy, chemotherapy, surveillance
Available Penile CancerSquamous cell carcinoma, TNM staging, organ-sparing surgery, nodal management, DSNB
AvailablePatient information on the main non-oncological urological conditions
Lower urinary tract symptoms, BPH, medical therapy, endoscopic and laser surgery
Available Overactive Bladder (OAB)Urgency, frequency, urge incontinence, anticholinergic therapy, neuromodulation
Available Female Genitourinary ProlapseCystocele, rectocele, uterine prolapse, surgical repair, mesh, urinary incontinence
Available Erectile DysfunctionPathophysiology, diagnosis, medical and surgical treatment, sexual rehabilitation after prostatectomy
Available Scrotal PathologyHydrocele, varicocele, epididymitis, testicular torsion, spermatocele
Available Ureteropelvic Junction ObstructionUPJ obstruction, robotic pyeloplasty, Anderson-Hynes technique, follow-up
Available Ureteral StricturesIatrogenic aetiology, buccal mucosal ureteroplasty, psoas hitch, ileal ureter
AvailableUpdated in real time from PubMed — Novara Giacomo
For clinical enquiries, research collaborations, or academic matters
Tel: +39 049 099 0854
Urology Unit, Padova University Hospital
Via Giustiniani 2, 35128 Padova, Italy
DiSCOG — University of Padova
Via Giustiniani 2, 35128 Padova, Italy
⚠️ The information on this website is intended for educational and informational purposes only. It does not replace the advice of a specialist physician. For personal clinical matters, please consult your general practitioner or a urologist.